Medical devices, healthcare technology and the business of care
510(k) clearance · K262030

Aventus Thrombectomy System

Inquis Medical · Decision date Jul 15, 2026

FDA DECISIONK262030

What did the FDA decide?

FDA records K262030 as a 510(k) premarket notification, with a decision dated Jul 15, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Jul 15, 2026

FDA source record

Regulatory record facts

Identifier
K262030
Regulatory pathway
510(k) premarket notification
Product code
QEZ
Decision code
SESE
Decision date
Jul 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aspiration Thrombectomy Catheter.

Product code
QEZ
FDA device class
2

FDA decision timeline

  1. K262030 received

    Application receipt date recorded by FDA.

  2. K262030 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QEZ

Product / regulatory recordCompanyPathwayDecision dateSource
Expanse Medical, Inc.510(k) clearanceOct 26, 2026FDA
MicroVention, Inc., d/b/a Terumo Neuro510(k) clearanceSep 3, 2026FDA
Inquis Medical510(k) clearanceJul 27, 2026FDA
Medtronic Interventional Vascular, Inc.510(k) clearanceApr 23, 2026FDA
Expanse Medical, Inc.510(k) clearanceMar 20, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Inquis Medical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Menlo Park, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records